Far East Horizon Limited (HKG:3360)

Intra-Cellular Therapies Statistics

Total Valuation

HKG:3360 has a market cap or net worth of HKD 37.71 billion.

Market Cap	37.71B
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	Sep 9, 2025

Share Statistics

HKG:3360 has 4.76 billion shares outstanding. The number of shares has decreased by -3.16% in one year.

Current Share Class	4.76B
Shares Outstanding	4.76B
Shares Change (YoY)	-3.16%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	27.60%
Float	2.94B

Valuation Ratios

The trailing PE ratio is 8.39 and the forward PE ratio is 7.68.

PE Ratio	8.39
Forward PE	7.68
PS Ratio	0.97
PB Ratio	0.58
P/TBV Ratio	0.68
P/FCF Ratio	11.11
P/OCF Ratio	3.76
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 4.49.

Current Ratio	1.66
Quick Ratio	1.62
Debt / Equity	4.49
Debt / EBITDA	n/a
Debt / FCF	86.17
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.42%.

Return on Equity (ROE)	7.42%
Return on Assets (ROA)	1.21%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	2.10M
Profits Per Employee	234,290
Employee Count	19,171
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:3360 has paid 3.98 billion in taxes.

Income Tax	3.98B
Effective Tax Rate	45.22%

Stock Price Statistics

The stock price has increased by +48.23% in the last 52 weeks. The beta is 0.60, so HKG:3360's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+48.23%
50-Day Moving Average	7.16
200-Day Moving Average	6.14
Relative Strength Index (RSI)	58.01
Average Volume (20 Days)	9,099,995

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3360 had revenue of HKD 38.70 billion and earned 4.32 billion in profits. Earnings per share was 0.94.

Revenue	38.70B
Gross Profit	16.23B
Operating Income	6.51B
Pretax Income	8.79B
Net Income	4.32B
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	0.94

Balance Sheet

The company has 23.46 billion in cash and 292.58 billion in debt, giving a net cash position of -269.12 billion or -56.52 per share.

Cash & Cash Equivalents	23.46B
Total Debt	292.58B
Net Cash	-269.12B
Net Cash Per Share	-56.52
Equity (Book Value)	65.17B
Book Value Per Share	11.74
Working Capital	126.95B

Cash Flow

In the last 12 months, operating cash flow was 10.03 billion and capital expenditures -6.63 billion, giving a free cash flow of 3.40 billion.

Operating Cash Flow	10.03B
Capital Expenditures	-6.63B
Free Cash Flow	3.40B
FCF Per Share	0.71

Margins

Gross margin is 41.93%, with operating and profit margins of 16.83% and 11.16%.

Gross Margin	41.93%
Operating Margin	16.83%
Pretax Margin	22.73%
Profit Margin	11.16%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	8.77%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 7.58%.

Dividend Per Share	0.60
Dividend Yield	7.58%
Dividend Growth (YoY)	-34.00%
Years of Dividend Growth	5
Payout Ratio	55.58%
Buyback Yield	3.16%
Shareholder Yield	10.86%
Earnings Yield	11.45%
FCF Yield	9.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5